highest dose of glp-1 🚨 FDA just approved Foundayo™ (orforglipron) — Lilly's once-daily oral GLP- 1 for obesity. The headline: 12.4% average body weight reduction at the over 72 weeks in ATTAIN-1. That's −27 lbs Going down in dose 💉
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

















:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)






